---
$id: https://graph.org.ai/products/commodity/51281637
$type: Product
source: UNSPSC
code: "51281637"
title: "Bekanamycin sulfate"
class: "51281600"
classTitle: "Aminoglycosides"
family: "51280000"
familyTitle: "Antibacterials"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Bekanamycin sulfate

**UNSPSC Code**: 51281637
**Class**: [Aminoglycosides](Aminoglycosides.mdx)
**Family**: [Antibacterials](../Antibacterials.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes the sulfate form of an aminoglycoside antibiotic with the molecular structure C18H37N5O10, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier, 15JT14C3GI chemically known as (1r,2s,3s,4r,6s)-4,6-diamino-3-((3-amino-3-deoxy-.alpha.-d-glucopyranosyl)oxy)-2-hydroxycyclohexyl 2,6-diamino-2,6-dideoxy-.alpha.-d-glucopyranoside, but more commonly known as bekanamycin, which bears US NIH Compound Identifier 816. European Medicines Agency schedules Bekanamycin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05684MIG. The term BEKANAMYCIN is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 25 , no. 10 1971, list 11. ). Most nations, for tariff and trade purposes, schedule bekanamycin sulfate under HS 29419000 and SITC 54139. As of Q4 2014, BEKANAMYCIN SULFATE remains US FDA's Preferred Term for this commodity. Bekanamycin sulfate bears US NLM identifiers UMLS ID C0888075 and NCI Concept Code C76153. SMILES: C1[C@@H]([C@H]([C@@H]([C@H]([C@@H]1N)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)N)O)O)O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CN)O)O)N)N.OS(=O)(=O)O.

